Gilead ’s Boosting Agent Cobicistat for HIV Therapy as Effective as Ritonavir in Pivotal Phase 3 Study
24 July 2012 | By Gilead Sciences, Inc.
Full clinical trial results from a pivotal Phase 3 study...
List view / Grid view
24 July 2012 | By Gilead Sciences, Inc.
Full clinical trial results from a pivotal Phase 3 study...
23 July 2012 | By Pfizer
Co-primary clinical endpoints not met in study of patients with Alzheimer’s disease who carry the ApoE4 genotype...
23 July 2012 | By Roche
Almost four times as many patients achieve remission with RoActemra (tocilizumab) compared to Humira (adalimumab)...
23 July 2012 | By Boehringer Ingelheim
FX125L is a small molecule...
22 July 2012 | By Eli Lilly and Company
Results from a pharmacokinetic study...
20 July 2012 | By Pfizer
“The CHMP’s positive opinion brings us a step closer..."
20 July 2012 | By Novartis
The US FDA has approved Afinitor® tablets...
20 July 2012 | By Sanofi
ODYSSEY will comprise over 10 clinical trials...
19 July 2012 | By Catalent Pharma Solutions
Why single use is ideal for cell line development and bio-manufacturing...
19 July 2012 | By Pfizer
“The Court’s decision recognizes the infringement & validity of our LYRICA® patents..."
19 July 2012 | By Roche
The system will be available in the United States in the second half of 2012...
19 July 2012 | By Pfizer
The EMA has accepted for review the MAA for bazedoxifene/conjugated estrogens...
19 July 2012 | By Kapler Communications Ltd
On 13 July, Dame Janet Trotter, presented Tim Freeman with the 2012 Queen’s Award...
19 July 2012 | By Bristol-Myers Squibb Company
Results of the phase III BRISK-FL clinical trial...
19 July 2012 | By Merck
Initiative is designed to improve access to care in support of U.S. National HIV/AIDS Strategy...